(UT7USA) UBS(Lux)Fund Solutions – - Ratings and Ratios
Exchange: SW •
Country: Switzerland •
Currency: USD •
Type: Etf •
ISIN: LU0721552973
Bond, Investment, Fund
Description: UT7USA UBS(Lux)Fund Solutions –
URL: http://www.credit-suisse.com Index: Morningstar US Govt Bd TR USD
Additional Sources for UT7USA ETF
UT7USA ETF Overview
| Market Cap in USD | 16m |
| Category | USD Government Bond |
| TER | 0.10% |
| IPO / Inception | 2012-02-02 |
UT7USA ETF Ratings
| Growth Rating | -25.9 |
| Fundamental | - |
| Dividend Rating | 37.2 |
| Rel. Strength | 7.61 |
| Analysts | - |
| Fair Price Momentum | 35.97 USD |
| Fair Price DCF | - |
UT7USA Dividends
| Dividend Yield 12m | 1.44% |
| Yield on Cost 5y | 1.25% |
| Annual Growth 5y | 2.80% |
| Payout Consistency | 89.1% |
| Payout Ratio | % |
UT7USA Growth Ratios
| Growth Correlation 3m | 32.4% |
| Growth Correlation 12m | 21.5% |
| Growth Correlation 5y | -64.6% |
| CAGR 5y | -2.76% |
| CAGR/Max DD 5y | -0.12 |
| Sharpe Ratio 12m | -0.26 |
| Alpha | 1.02 |
| Beta | -0.121 |
| Volatility | 7.05% |
| Current Volume | 0.1k |
| Average Volume 20d | 0.1k |
| Stop Loss | 37.2 (-3.5%) |
What is the price of UT7USA shares?
As of July 09, 2025, the stock is trading at USD 38.55 with a total of 81 shares traded.
Over the past week, the price has changed by -1.10%, over one month by +0.81%, over three months by -0.16% and over the past year by +4.07%.
As of July 09, 2025, the stock is trading at USD 38.55 with a total of 81 shares traded.
Over the past week, the price has changed by -1.10%, over one month by +0.81%, over three months by -0.16% and over the past year by +4.07%.
Is UBS(Lux)Fund Solutions – a good stock to buy?
Probably not. Based on ValueRay´s Analyses, UBS(Lux)Fund Solutions – (SW:UT7USA) is currently (July 2025) not a good stock to buy. It has a ValueRay Growth Rating of -25.94 and therefor a somwhat technical negative rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of UT7USA is around 35.97 USD . This means that UT7USA is currently overvalued and has a potential downside of -6.69%.
Probably not. Based on ValueRay´s Analyses, UBS(Lux)Fund Solutions – (SW:UT7USA) is currently (July 2025) not a good stock to buy. It has a ValueRay Growth Rating of -25.94 and therefor a somwhat technical negative rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of UT7USA is around 35.97 USD . This means that UT7USA is currently overvalued and has a potential downside of -6.69%.
Is UT7USA a buy, sell or hold?
UBS(Lux)Fund Solutions – has no consensus analysts rating.
UBS(Lux)Fund Solutions – has no consensus analysts rating.
What are the forecasts for UT7USA share price target?
According to our own proprietary Forecast Model, UT7USA UBS(Lux)Fund Solutions – will be worth about 38.8 in July 2026. The stock is currently trading at 38.55. This means that the stock has a potential upside of +0.75%.
According to our own proprietary Forecast Model, UT7USA UBS(Lux)Fund Solutions – will be worth about 38.8 in July 2026. The stock is currently trading at 38.55. This means that the stock has a potential upside of +0.75%.
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 38.8 | 0.8% |